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Abstract
Background: Reflux esophagitis (RE) is increasing in prevalence in China. There are very few studies on the prevalence 
and factors related to RE in patients with chronic liver diseases. The aims of this study were to determine the 
prevalence of RE by endoscopy in patients with chronic liver diseases and the possible related predictors of RE.
Methods: A total of 1,280 patients with chronic liver disease and 29 patients with acute hepatitis A or E were 
prospectively evaluated. There were 879 and 401 patients with liver cirrhosis or chronic hepatitis, respectively. RE was 
classified by endoscopy according to the Los Angeles classification scheme.
Results: RE was diagnosed in 36.4% (469/1280) of the chronic liver disease patients, which was significantly higher 
than in the acute hepatitis patients (10.3% [3/29], P < 0.001). RE accounted for 43.0%, 9.7%, and 60.2% of patients with 
liver cirrhosis, chronic hepatitis(mild and medium), and liver failure, respectively. A high prevalence of RE existed in 
patients with liver failure and/or Child B and C liver cirrhosis, with typical symptoms of RE in 21.3% of the patients (100/
469). There was a significant relationship between gender, age, ascites, and RE.
Conclusions: The high prevalence of RE among upper endoscopies of patients with severe chronic liver disease was 
demonstrated. Asymptomatic RE was more common in cirrhotic and liver failure patients. The role of RE in variceal 
bleeding, however, needs to be demonstrated.
Background
Gastroesophageal reflux disease (GERD), a highly preva-
lent disorder, is defined as reflux of gastroduodenal con-
tent to the esophageus, and includes reflux esophagitis
(RE) and Barrett's esophagus [1,2]. However, only one-
half of GERD patients present with esophageal erosions,
namely RE. The symptoms of GERD typically include
dyspepsia, pyrosis, or tissue damage outside the esopha-
gus, such as the pharynx, larynx, and trachea [3,4]. GERD
is very common in Western countries; 7%~10% of adults
have pyrosis daily and 30% ~ 40% have pyrosis on a
monthly basis [2]. An epidemiologic survey in China
showed the incidence of pyrosis and dyspepsia to be
8.97%[1]. The incidence of GERD, confirmed using 24-
hour esophageal pH monitoring, is 5.77%, and RE con-
firmed by endoscopy is 1.92%, which is lower than in
Western countries [1]. The causes and mechanisms of
GERD have not been elucidated [5,6]. Patients with
chronic liver disease patients, especially patients with
portal hypertension and liver cirrhosis, have clinical man-
ifestations, such as esophageal varices, ascites, and
edema. Some studies have been conducted regarding the
role of esophageal varices in the development of esopha-
geal motor disorders and abnormal gastroesophageal
reflux in these patients [7,8]. Ascites could be a factor
promoting gastroesophageal reflux and it has been ques-
tioned whether or not reflux would favor the rupture of
varices [9,10]. However, there are few studies on the prev-
alence of RE and factors related to RE in patients with
chronic liver disease. Therefore, the aims of this study
were to evaluate the prevalence of RE confirmed by
endoscopy in patients with chronic liver disease patients
and the factors related to RE.
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Methods
Patients
Between January 2008 and January 2009, patients with
chronic liver disease who submitted to endoscopy were
prospectively evaluated. All patients came from the inpa-
tients clinic department of Beijing Youan Hosital of Capi-
tal Medical University. We excluded patients with
systemic disease related to esophageal motor disorders
and/or gastroesophageal RE (progressive systemic sclero-
sis, diabetes mellitus, and neuromuscular disorders),
alcohol abusers until 6 months before this study, and
chronic users of drugs that influence esophageal motility
(calcium channel blockers, theophyline, and nitrates). All
patients were evaluated by the same associate chief physi-
cian according to a protocol for classifying etiology,
Child-Pugh score, ascites, and GERD symptoms, such as
pyrosis and/or dyspepsia. A diagnostic work-up of
chronic liver disease was performed, including a clinical
history, physical examination, laboratory tests, and/or
liver pathology assessment according to the criteria sug-
gested by the Chinese Medical Association for Liver Dis-
eases in 2000 [11]. In brief, the diagnostic criteria of liver
failure was based on the history of chronic liver disease,
significant digestive symptoms and/or extreme fatigue,
hepatic encephalopathy, and/or ascites, prothrombin
activity (PTA) < 40%, and serum total bilirubin (TBIL) >
10 times the upper limit of normal. Of the enrolled
patients, 29 patients with acute hepatitis A or E, who had
undergone endoscopy, were considered as controls. The
complications and reflux disease questionnaire (RDQ;
AstraZeneca R&D, Wuxi, China), such as pyrosis and/or
dyspepsia, were noted. The study was performed in
accordance with the principles of the Declaration of Hel-
sinki. The study program was explained to the patients
and/or their relatives and informed consent forms were
obtained. The study was approved by the Ethical Com-
mittee at Beijing You'an Hospital of Capital Medical Uni-
versity.
Upper gastrointestinal endoscopy
All patients underwent upper gastrointestinal endoscopy
(OlympusXQ260; Olympus, Japan) to evaluate esopha-
geal varices (EV), classified as small (diameter, < 3 mm),
medium (diameter, 3-6 mm), or large (diameter, > 6
mm)[12]. RE, if present, was classified according to Los
Angeles classification standards [13], as follows: grade A,
isolated erosions, the damage was limited to the folds of
mucosa and the length is < 0.5 cm; grade B, confluent but
not circumferential erosions, the damage is limited to the
folds of mucosa, one of which is > 0.5 cm in length; grade
C, confluent and circumferential erosions, the mutual
integration of mucosal damage, but < 75% of the esopha-
gus; and grade D, confluent and circumferential erosions
and encroachment is > 75% of the esophageal circumfer-
ence. Hiatal hernia was considered to be present if the
gastroesophageal junction was 2 cm above the diaphrag-
matic impression.
Data collection
All patients had blood drawn for a complete blood count
and analysis of prothrombin, albumin, alanine transami-
nase (ALT), aspartate transaminase (AST), alkaline phos-
phatase, gamma glutamyl transferase, bilirubin,
cholesterol, creatinine, urea nitrogen, Na+, Cl-, and K+
using an OLYMPUS automatic biochemical analyzer
(OLYMPUS-AU640). In addition, blood was obtained for
detection of markers for hepatitis A and B (Abbott Labo-
ratories, Abbott Park, IL, USA), and C and E (reagents
from Beijing Wantai Pharmaceutical Company, Beijing,
China) using ELISA. The quality control for blood tests
was administered by the National Center for Clinical Lab-
oratory.
Data analysis
RE related to the following variables was analyzed: pres-
ence of ascites, Child-Pugh score, gender, age, and EV
size. The statistical analyses were performed using SPSS
software, version 13.0 for Windows. Dichotomous vari-
able data were analyzed by the Fisher exact test and χ2
analysis. The differences were considered statistically sig-
nificant when p < 0.05.
Results
Characteristics of patients
A total of 1,280 patients met the inclusion criteria. There
were 897 males (70.1%) and 383 females (29.9%), with a
mean age of 54.3 ± 10.2 years (range, 17-73 years). The
diagnosis of liver cirrhosis was made by histopathologic
or clinical criteria in 879 patients (66.7%). The etiology of
liver cirrhosis included hepatitis B in 757 patients
(86.1%), alcohol in 67 patients (7.6%), hepatitis C in 51
patients (5.8%), and cryptogenic in 4 patients (0.45%).
The patients with liver cirrhosis were classified as follows:
Child A, 166 patients (18.9%); Child B, 324 patients
(36.9%); and Child C, 389 patients (44.3%). Ascites was
present in 672 patients (76.5%) with liver cirrhosis. EV
were present in 796 patients (90.5%) with liver cirrhosis.
The diagnosis of chronic hepatitis was made by histo-
pathologic or clinical criteria in 401 patients. The etiol-
ogy of chronic hepatitis included hepatitis B in 334
patients (83.3%), autoimmune hepatitis in 13 patients
(3.2%), hepatitis C in 21 patients (5.2%), and cryptogenic
hepatitis in 33 patients (8.2%). Ninety-seven (24.2%), 201
(50.1%), and 103 patients (25.7%) had mild, moderate,
and liver failure, respectively.Li et al. BMC Gastroenterology 2010, 10:54
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Prevalence of RE
The prevalence of RE was 36.4% (469/1280) in patients
with chronic liver disease, which was significantly higher
than the control patients (10.3% [3/29], P < 0.001). RE
accounted for 43.0%, 9.7%, and 60.2% of patients with
liver cirrhosis, chronic hepatitis(mild and medium), and
liver failure, respectively. The high prevalence of RE in
patients with liver failure or Child B and C liver cirrhosis
is shown in Table 1. Grades C and D of RE in Child C or
liver failure patients was more common than Child A or B
patients (Figure 1). Thus, there was a positive relationship
between the severity of liver function damage and RE.
Clinical symptoms
Typical symptoms of RE were present in 21.3% of patients
(100/469) and mainly occurred in patients with chronic
hepatitis (43%). However, the patients with the most
severe cirrhosis had asymptomatic manifestations from
RE, but suffered from other symptoms. Dyspepsia and
pyrosis only accounted for 12.3% and 10.4% of cirrhotic
patients, respectively.
Related variables analysis
Age and gender
RE was more common in males (43.1% [387/897]) than
females (21.4% [82/383]; χ2 = 29.1, P < 0.0001). The prev-
alence of RE increased with age. The occurrence of RE
accounted for 63.1% in patients > 60 years of age with
chronic liver disease. The prevalence of RE was only
20.0% in patients < 20 years of age with chronic liver dis-
ease (Figure 2).
Ascites and RE
Ascites was present in 672 patients with liver cirrhosis;
312 patients (46.4%) presented with RE. In the 207
patients without ascites, 66 (31.9%) had RE. There was a
significant relationship between ascites and RE (χ2 = 5.76,
P = 0.016).
EV size and RE
Of the patients with cirrhosis and EV, 44.7% (356/796)
had RE. Twenty-two of 83 patients (26.5%) without EV
had RE. Sixty-one of 158 patients (38.6%) with small size
EV had RE. RE was found in 43.0% (163/379) and 51.0%
(132/259) of patients with medium and large EV, respec-
tively. There was no significant relationship between EV
size and RE (χ2 = 2.6, P = 0.11).
Discussion
GERD, which is divided into RE and Barrett's Esophagus,
is common in Western countries [2,14]. The incidence of
GERD is 5.77% in the general Chinese population [1]. It
has been reported that the incidence of GERD is 65% in
patients with decompensated cirrhosis [15]. In this study,
the prevalence of RE, as confirmed by endoscopy, was
36.4% in patients with chronic liver disease, which was
significantly higher than patients with acute hepatitis
(10.3%). The prevalence of RE was 43.0% in patients with
liver cirrhosis and 23.3% in patients with chronic hepati-
tis patients. The highest prevalence of RE existed
between patients with liver failure or Child B and C liver
c i r r h o s i s .  W e  a l s o  f o u n d  t h a t  i n  p a t i e n t s  w i t h  c h r o n i c
liver disease, RE was more common in males (43.1%) than
in females (21.4%). RE is becoming increasingly more
prevalent in older patients with chronic liver disease. The
prevalence of RE accounted for 63.1% in patients > 60
years of age; however, RE occurred in 20.0% of patients <
20 years of age with chronic liver disease. Therefore,
there is a relationship between the high prevalence of RE
among patients with chronic liver disease and severity of
liver damage and age.
GERD clinical symptoms can be typical, such as dys-
pepsia and/or pyrosis. The typical symptoms of RE were
present in 21.3% of those patients and mainly occurred in
patients with chronic hepatitis (43%). However, most cir-
rhotic patients with RE were asymptomatic. Dyspepsia
Table 1: The prevalence of RE in chronic liver disease patients
GERD# Liver cirrhosis (n = 879) Chronis hepatitis (n = 401)
Child A Child B Child C Mild Medium Liver failure
n = 166 n = 324 n = 389 n = 97 n = 201 n = 103
A 24 44 34 5 19 11
B1 3 5 9 6 9 131 5 *
C 9 35* 65** 0 1 17**
D 0 5** 21** 0 0 19**
Total 46(27.7%) 143(44.1%) 189(48.6%)* 6(6.2%) 23(11.4%) 62(60.2%)**
Compared with Child A, mild, or moderate hepatitis: *χ2 = 5.76~9.38, P < 0.05,
**χ2 = 10.6~20.33, P < 0.001. #The grade of A, B, C, and D of RE was classified by endoscopy according to Los Angeles classification standards.Li et al. BMC Gastroenterology 2010, 10:54
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and pyrosis only accounted for 12.3% and 10.4%, of cir-
rhotic patients, respectively. Therefore, in chronic liver
disease patients with RE, the clinician may not have men-
tioned this because of asymptomatic RE. Questioning
patients about atypical reflux symptoms must be a part of
the cirrhotic patient's history. If present, a work-up for
Figure 1 The grade of RE in different stage cirrhotic patients. The grade C and D of RE in Child C patients was more common than Child A or B 
patients, * P < 0.05~0.001. There was no difference in grade A and B of RE in cirrhotic patients with Child A, B, and C.**P > 0.05.
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Figure 2 The relationship between RE and age. The prevalence of RE increased with age. compared with patients < 20 years of age, a: χ2 = 0.89, P 
= 0.66; b: χ2 = 3.65, P = 0.057; c: χ2 = 3.26, P = 0.07; d: χ2 = 8.98, P = 0.003; e: χ2 = 17.6, P = 0.0000.
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GERD must be done with endoscopy or the patient
should be empirically treated.
The causes and the mechanism of liver disease in
patients with RE have not been elucidated. It has been
confirmed that the high incidence of RE in patients with
chronic liver disease is related to the following factors: Ђ
There are changes in gastrointestinal hormones in
patients with liver cirrhosis: Studies have shown that
plasma vasoactive peptide and neurotensin in patients
with liver cirrhosis are significantly higher than in the
normal population, and vasoactive peptides and neuro-
tensin are known to reduce the pressure of the lower
esophageal sphincter (LES), which facilitates reflux of the
stomach contents[5,7]. ? Emptying of the stomach is
delayed: It has been reported that gastric half-emptying
of liquid food is delayed in patients with liver cirrhosis,
and the function of gastric emptying is influenced by the
extent of liver function damage[16,17]. ? Ascites induces
an increase in intra-abdominal pressure, compressing the
stomach and the stomach contents reflux[9,15]. ? The EV
influence esophageal emptying, so that the contact time
of refluxed objects with the esophageal mucosa is
extended[18]. ? EV lead to LES dysfunction, which make
the stomach contents reflux easily. It has recently been
shown that the nitric oxide (NO) concentration is
increased significantly in patients with liver disease, while
NO is closely related to transient LES relaxation[19]. The
current view showed that NO may be an activated factor
of transient LES relaxation, which mediates esophageal
LES smooth muscle relaxation and plays an important
r ole  i n GERD .  In t his  s t udy , t he r e  was  no r e la t ions hip
between ascites and RE.
GERD in cirrhotic patients with EV has been studied
for many years, and great importance has been paid to
esophageal dyspepsia as a risk factor for the rupture and
bleeding of EV[18]. Other studies have reinforced these
initial findings as they showed a higher prevalence of
esophagitis and dyspepsia in cirrhotic patients with non-
bleeding varices and a lower LES pressure in cirrhotic
patients with massive ascites [9]. However, later studies
have not supported this hypothesis because a lower LES
pressure or a higher incidence of GERD was not demon-
strated in this group of patients [15]. In the last few
decades, as variceal bleeding continued to be a severe
complication, new risk factors for rupture have been eval-
uated [19,20]. GERD was again studied and the preva-
lence among cirrhotic patients with EV has been studied
[9,10]. Therefore, in cirrhotic patients, increased contact
time between dyspepsia and EV could lead to the even-
tual erosion of the mucosa and EV bleeding. In our study,
44.7% of cirrhotic patients with varices had RE. The ten-
dency of a high prevalence (51.0%) of RE was observed in
large EV in cirrhotic patients (43.0% in medium and
38.6% in small EV). There was no significant relationship
between EV size and RE.
Conclusions
The high prevalence of RE detected during upper endos-
copies in patients with chronic liver diseases has been
demonstrated. There was no significant correlation
between ascites, EV size, and high prevalence of RE in
cirrhotic patients. It should be mentioned, however, that
asymptomatic RE is more common in cirrhotic and liver
failure patients. The role of RE in variceal bleeding, how-
ever, needs to be demonstrated.
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